Valuation: AbbVie Inc.

Market Cap 468B 401B 375B 344B 645B 44,798B 653B 4,434B 1,729B 22,504B 1,758B 1,720B 74,435B P/E 2026 *
33.8x
P/E 2027 * 25x
Enterprise Value 529B 453B 424B 388B 728B 50,586B 738B 5,007B 1,952B 25,412B 1,985B 1,942B 84,052B EV / Sales 2026 *
7.82x
EV / Sales 2027 * 7.07x
Free-Float
95.71%
Yield 2026 *
2.59%
Yield 2027 * 2.72%
1 day+1.20%
1 week+6.21%
Current month+5.59%
1 month+4.60%
3 months+22.84%
6 months+17.86%
Current year+15.96%
1 week 248.31
Extreme 248.31
266.96
1 month 241.2
Extreme 241.2
267.47
Current year 190.75
Extreme 190.75
267.47
1 year 190.75
Extreme 190.75
267.47
3 years 135.85
Extreme 135.85
267.47
5 years 105.56
Extreme 105.56
267.47
10 years 55.06
Extreme 55.0623
267.47
Manager TitleAgeSince
Chief Executive Officer 55 01/07/2024
Director of Finance/CFO 59 23/06/2022
Chief Tech/Sci/R&D Officer - 01/03/2024
Director TitleAgeSince
Director/Board Member 65 01/01/2013
Director/Board Member 74 01/01/2013
Director/Board Member 69 01/01/2013
Date Insider Type Main position Quantity % Market Cap.
8/14/26 A Fiscal year

Executive/Senior Manager

98,130 0.0056%
6/30/26 A Free

Director

62 0.0000%
6/30/26 A Free

Director

134 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+1.20%+6.21%+25.81%+78.74% 468B
+0.88%+6.38%+76.40%+126.75% 1,119B
+1.07%+3.80%+50.73%+62.78% 651B
+1.02%+5.77%+43.63%+48.43% 374B
+0.85%+4.07%+24.97%+40.58% 302B
+1.26%+6.81%+2.27%+14.41% 259B
+1.88%+5.81%+49.57%+70.53% 238B
+1.59%+2.09%-17.33%-52.62% 208B
+1.87%+5.61%+27.32%+91.38% 181B
+1.01%+4.78%+8.46%-23.81% 160B
Average +1.26%+4.85%+29.18%+45.72% 395.98B
Weighted average by Cap. +1.13%+5.03%+42.81%+68.75%

Financials

2026 *2027 *
Net sales 67.58B 57.89B 54.17B 49.59B 93.06B 6,466B 94.29B 640B 250B 3,248B 254B 248B 10,744B 73.52B 62.98B 58.93B 53.94B 101B 7,034B 103B 696B 271B 3,534B 276B 270B 11,688B
Net income 13.86B 11.87B 11.11B 10.17B 19.09B 1,326B 19.34B 131B 51.19B 666B 52.05B 50.92B 2,204B 18.91B 16.2B 15.16B 13.88B 26.04B 1,810B 26.39B 179B 69.85B 909B 71.02B 69.47B 3,007B
Net Debt 60.49B 51.82B 48.48B 44.38B 83.29B 5,788B 84.39B 573B 223B 2,907B 227B 222B 9,617B 51.66B 44.25B 41.41B 37.9B 71.13B 4,943B 72.07B 489B 191B 2,483B 194B 190B 8,213B
Logo AbbVie Inc.
AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (76.2%), Germany (2.8%), Japan (2.1%), Canada (2%), China (1.6%), France (1.3%), the United Kingdom (1%), Spain (1%), Italy (0.9%), Brazil (0.8%), Australia (0.8%), and Other (9.5%).
Employees
57,000
Date Price Change Volume
21/08/26 $264.96 +1.20% 5,157,192
20/08/26 $261.83 -1.56% 5,228,907
19/08/26 $265.97 +2.72% 5,535,972
18/08/26 $258.92 +3.43% 5,010,229
17/08/26 $250.33 +0.35% 4,648,771
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
264.96USD
Average target price
276.59USD
Spread / Average Target
+4.39%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ABBV Stock